Women's Gastrointestinal Medicine
COVID-19 Preparedness and Response
Safety is our top priority
We want to assure you that the we are here for you. While the coronavirus has changed much of our daily lives, one thing that has remained constant is our commitment to providing you with the best, safest care possible.
At the Women's Medicine Collaborative, your safety is our top priority. We recognize that this is a time of many questions and concerns. Our Women’s Medicine care team is here to support you. We also know completing a treatment plan is associated with the best outcomes for patients. That is why we worked closely with our infection prevention and infectious diseases teams to be able to provide the care you need in a safe environment.
At the Forefront of Women's Gastrointestinal Health
At the Center for Women's Gastrointestinal Medicine at the Women's Medicine Collaborative, we offer a comprehensive, multidisciplinary approach to women's gastrointestinal issues. Our all-female staff is at the forefront of women's gastrointestinal health, offering clinical expertise, state-of-the-art technology and academic excellence with a caring, personal touch.
A Multidisciplinary Approach to GI Treatment
At our center, we take a multidisciplinary approach, working closely with obstetricians, midwives, gynecologists and other specialists, as needed. We participate in a gastroenterology tumor board and provide comprehensive consultation and follow-up care, as well as nutrition consultation.
Whatever services you require, we always take the time to discuss your diagnosis and treatment options with you, and to answer your questions thoroughly.
Our physicians are board certified in internal medicine and serve on the faculty of The Warren Alpert Medical School of Brown University. Our team members are leaders in the field of women's gastrointestinal medicine and have authored multiple text books and articles in medical journals.
Research is currently being conducted to learn more about gastrointestinal issues and how they affect our patients. Several clinical trials are currently open.